Arrowhead Pharmaceuticals Inc (ARWR) Insider Trading
- $301,336.35
- $143,830,412.54
- Dec. 18, 2024
- Christopher Richard Anzalone
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Feb. 8, 2019 | COO | 46,167 | $15.34 | Sell | $708,201.78 | |
Feb. 5, 2019 | COO | 22,500 | $14.48 | Sell | $325,800.00 | |
Feb. 1, 2019 | COO | 28,500 | $13.85 | Sell | $394,725.00 | |
Jan. 23, 2019 | COO | 169,500 | $13.54 | Sell | $2,295,030.00 | |
Jan. 22, 2019 | Director | 3,000 | $13.58 | Sell | $40,740.00 | |
Jan. 18, 2019 | General Counsel | 72,000 | $14.43 | Sell | $1,038,960.00 | |
Jan. 17, 2019 | CFO | 81,875 | $14.55 | Sell | $1,191,281.25 | |
Jan. 14, 2019 | VP | 40,500 | $14.34 | Sell | $580,770.00 | |
Jan. 14, 2019 | COO | 42,666 | $14.40 | Sell | $614,390.40 | |
Jan. 11, 2019 | Director | 8,500 | $14.77 | Sell | $125,545.00 | |
Jan. 2, 2019 | CFO | 8,333 | $11.98 | Sell | $99,829.34 | |
Jan. 2, 2019 | COO | 20,000 | $11.98 | Sell | $239,600.00 | |
Dec. 27, 2018 | Director | 3,000 | $12.00 | Sell | $36,000.00 | |
Dec. 19, 2018 | CEO | 90,000 | $13.92 | Sell | $1,252,800.00 | |
Dec. 12, 2018 | CEO | 90,000 | $14.07 | Sell | $1,266,300.00 | |
Nov. 23, 2018 | Director | 3,000 | $12.74 | Sell | $38,220.00 | |
Nov. 9, 2018 | CEO | 81,500 | $14.39 | Sell | $1,172,785.00 | |
Oct. 19, 2018 | VP | 131,137 | $13.49 | Sell | $1,769,038.13 | |
Sept. 6, 2018 | CFO | 45,000 | $19.34 | Sell | $870,300.00 | |
Sept. 4, 2018 | CEO | 164,834 | $14.45 | Sell | $2,381,851.30 | |
Aug. 31, 2018 | CEO | 100,000 | $14.45 | Sell | $1,445,000.00 | |
June 19, 2018 | CFO | 20,000 | $14.01 | Sell | $280,200.00 | |
May 31, 2018 | CFO | 14,000 | $11.00 | Sell | $154,000.00 | |
April 24, 2018 | Director | 25,000 | $6.63 | Sell | $165,750.00 | |
March 27, 2018 | CFO | 20,000 | $8.00 | Sell | $160,000.00 | |
March 15, 2018 | CEO | 300,000 | $7.43 | Sell | $2,229,000.00 | |
March 13, 2018 | CEO | 100,000 | $7.43 | Sell | $743,000.00 | |
March 5, 2018 | COO | 20,000 | $6.73 | Sell | $134,600.00 | |
Jan. 1, 2018 | COO | 20,000 | $3.69 | Sell | $73,800.00 | |
Oct. 14, 2016 | Director | 12,000 | $6.72 | Sell | $80,640.00 | |
Aug. 23, 2016 | CFO | 6,900 | $8.00 | Sell | $55,200.00 | |
Aug. 22, 2016 | CFO | 13,100 | $8.00 | Sell | $104,800.00 | |
Dec. 30, 2015 | CFO | 23,347 | $6.13 | Sell | $143,117.11 | |
Oct. 28, 2015 | Director | 400 | $7.62 | Buy | $3,048.00 | |
Oct. 9, 2015 | Director | 1,900 | $6.19 | Buy | $11,761.00 | |
Jan. 5, 2015 | Insider | 15,000 | $8.01 | Sell | $120,150.00 | |
Oct. 15, 2014 | CEO | 16,000 | $6.32 | Buy | $101,120.00 | |
Oct. 1, 2014 | Director | 2,500 | $14.70 | Sell | $36,750.00 | |
Sept. 30, 2014 | Insider | 15,000 | $15.02 | Sell | $225,300.00 | |
Sept. 26, 2014 | Director | 2,000 | $15.24 | Sell | $30,480.00 | |
June 9, 2014 | Director | 22,000 | $14.32 | Sell | $315,040.00 | |
Feb. 12, 2014 | CFO | 16,000 | $18.77 | Sell | $300,320.00 | |
Feb. 7, 2014 | Director | 3,148 | $15.98 | Sell | $50,305.04 |
Insiders are both buying and selling Arrowhead Pharmaceuticals Inc stock.
The insider traders at Arrowhead Pharmaceuticals Inc are: Christopher Richard Anzalone, Kenneth Allen Myszkowski, Bruce D Given, Patrick O'brien, Douglas B Given, James C Hamilton, Douglas B. Given, Backer Marianne De, William D Waddill, Martin Javier San, Mauro Ferrari, Michael S Perry, Adeoye Y Olukotun, Charles Mckenney, David L Lewis, Hongbo Lu, James Hassard, Tracie Oliver, Victoria Vakiener, Zhen Li, Peter Brian Leone, and Edward W Frykman
The most active insider trader at Arrowhead Pharmaceuticals Inc is Christopher Richard Anzalone with 29 trades.
Christopher Richard Anzalone has sold the most Arrowhead Pharmaceuticals Inc stock with a total value of $63,003,719.17.
Christopher Richard Anzalone has bought the most Arrowhead Pharmaceuticals Inc stock with a total value of $202,240.00.
The most recent insider trade for Arrowhead Pharmaceuticals Inc was on Dec. 18, 2024.
The single biggest insider buy for Arrowhead Pharmaceuticals Inc was from Christopher Richard Anzalone with a total value of $101,120.00 on Oct. 15, 2014.
The single biggest insider sell for Arrowhead Pharmaceuticals Inc was from Patrick O'brien with a total value of $7,961,400.00 on Feb. 8, 2021.